Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12483)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 21, 2015 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Niccolai E, Taddei A, Prisco D, Amedei A. Gastric cancer and the epoch of immunotherapy approaches. World J Gastroenterol 2015; 21(19): 5778-5793 [PMID: 26019442 DOI: 10.3748/wjg.v21.i19.5778] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i19/5778.htm |
| Number | Citing Articles |
| 1 |
Qingwen Zeng, Leyan Li, Zongfeng Feng, Lianghua Luo, Jianbo Xiong, Zhigang Jie, Yi Cao, Zhengrong Li. LCP1 is a prognostic biomarker correlated with immune infiltrates in gastric cancer. Cancer Biomarkers 2021; 30(1): 105 doi: 10.3233/CBM-200006
|
| 2 |
Fadi E. El Rami, Hampartsoum B. Barsoumian, Gebran W. Khneizer. Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshell. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920967238
|
| 3 |
Riccardo Dolcetti, Valli De Re, Vincenzo Canzonieri. Immunotherapy for Gastric Cancer: Time for a Personalized Approach?. International Journal of Molecular Sciences 2018; 19(6): 1602 doi: 10.3390/ijms19061602
|
| 4 |
Bo Long, Zeyuan Yu, Huinian Zhou, Zhijian Ma, Yanxian Ren, Hao Zhan, Long Li, Hongtai Cao, Zuoyi Jiao. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis. International Journal of Surgery 2018; 56: 242 doi: 10.1016/j.ijsu.2018.06.033
|
| 5 |
Yang Qu, Xianhao Wang, Shuai Bai, Liling Niu, Gang Zhao, Yuan Yao, Bin Li, Hui Li. The effects of TNF‐α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer. International Journal of Cancer 2022; 150(8): 1373 doi: 10.1002/ijc.33873
|
| 6 |
A C West, K Tang, H Tye, L Yu, N Deng, M Najdovska, S J Lin, J J Balic, E Okochi-Takada, P McGuirk, B Keogh, W McCormack, P S Bhathal, M Reilly, M Oshima, T Ushijima, P Tan, B J Jenkins. Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer. Oncogene 2017; 36(36): 5134 doi: 10.1038/onc.2017.121
|
| 7 |
Sian Chen, Chenbin Chen, Yuanbo Hu, Ce Zhu, Xiaozhi Luo, Lizhu Wang, Xiang Wang, Xiangwei Sun, Xiaodong Chen, Wangkai Xie, Han Lou, Xielin Huang, Chao Li, Jun Xu, Xiangyang Xue, Xian Shen. Three-Dimensional Ex Vivo Culture for Drug Responses of Patient-Derived Gastric Cancer Tissue. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.614096
|
| 8 |
Zhaoxiong Zhang, Wenxin Zhang, Xin Liu, Yongjia Yan, Weihua Fu. T lymphocyte‑related immune response and immunotherapy in gastric cancer (Review). Oncology Letters 2024; 28(5) doi: 10.3892/ol.2024.14670
|
| 9 |
Daniela Cornelia Lazăr, Mihaela Flavia Avram, Ioan Romoșan, Mărioara Cornianu, Sorina Tăban, Adrian Goldiș. Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer. World Journal of Gastroenterology 2018; 24(32): 3583-3616 doi: 10.3748/wjg.v24.i32.3583
|
| 10 |
Zhengyang Zhou, Haiyang Zhang, Ting Deng, Tao Ning, Rui Liu, Dongying Liu, Ming Bai, Guoguang Ying, Yi Ba. RETRACTED: Exosomes Carrying MicroRNA-155 Target Forkhead Box O3 of Endothelial Cells and Promote Angiogenesis in Gastric Cancer. Molecular Therapy - Oncolytics 2019; 15: 223 doi: 10.1016/j.omto.2019.10.006
|
| 11 |
Md. Tofazzal Hossain, Md. Selim Reza, Yin Peng, Shengzhong Feng, Yanjie Wei. Identification of Key Genes as Potential Drug Targets for Gastric Cancer. Tsinghua Science and Technology 2023; 28(4): 649 doi: 10.26599/TST.2022.9010035
|
| 12 |
Osamu Kinoshita, Daisuke Ichikawa, Yusuke Ichijo, Shuhei Komatsu, Kazuma Okamoto, Mitsuo Kishimoto, Akio Yanagisawa, Eigo Otsuji. Histological evaluation for chemotherapeutic responses of metastatic lymph nodes in gastric cancer. World Journal of Gastroenterology 2015; 21(48): 13500-13506 doi: 10.3748/wjg.v21.i48.13500
|
| 13 |
Lu Ji, Wei Qian, Liming Gui, Zhongzhong Ji, Pan Yin, Guan Ning Lin, You Wang, Bin Ma, Wei-Qiang Gao. Blockade of β-Catenin–Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration. Cancer Research 2020; 80(10): 2004 doi: 10.1158/0008-5472.CAN-19-3074
|
| 14 |
璇 周. Research Progress of Oxidative Stress in Gastric Cancer. Advances in Clinical Medicine 2023; 13(03): 3919 doi: 10.12677/ACM.2023.133562
|
| 15 |
Zhongwei He, Xiangling Xiao, Shan Li, Yang Guo, Qiuyue Huang, Xin Shi, Xiaobo Wang, Ying Liu. Oridonin induces apoptosis and reverses drug resistance in cisplatin resistant human gastric cancer cells. Oncology Letters 2017; 14(2): 2499 doi: 10.3892/ol.2017.6421
|
| 16 |
HUI LIU, SHAOHUA LIANG, XI YANG, ZHAONING JI, WENYING ZHAO, XIAOBING YE, JING RUI. RNAi-mediated RPL34 knockdown suppresses the growth of human gastric cancer cells. Oncology Reports 2015; 34(5): 2267 doi: 10.3892/or.2015.4219
|
| 17 |
Wattana Leowattana, Pathomthep Leowattana, Tawithep Leowattana. Immunotherapy for advanced gastric cancer. World Journal of Methodology 2023; 13(3): 79-97 doi: 10.5662/wjm.v13.i3.79
Abstract(574) |
Core Tip(598) |
Full Article(HTML)(2216)
|
Full Article with Cover (PDF)-2288K(99)
|
Full Article (Word)-1032K(39)
|
Audio-541K(4)
|
Peer-Review Report-239K(65)
|
Answering Reviewers-82K(72)
|
Full Article (PDF)-2032K(165)
|
Full Article (XML)-264K(64)
|
Times Cited (6)
|
Total Visits (6277)
|
Open
|
| 18 |
Zhengyuan Wu, Lin Wang, Zhenpei Wen, Jun Yao. Integrated analysis identifies oxidative stress genes associated with progression and prognosis in gastric cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-82976-w
|
| 19 |
Wei-Zhong Sheng, Yu-Sheng Chen, Chuan-Tao Tu, Juan He, Bo Zhang, Wei-Dong Gao. <i>ANGPTL2</i> expression in gastric cancer tissues and cells and its biological behavior. World Journal of Gastroenterology 2016; 22(47): 10364-10370 doi: 10.3748/wjg.v22.i47.10364
|
| 20 |
Maria Grazia Refolo, Claudio Lotesoriere, Caterina Messa, Maria Gabriella Caruso, Rosalba D'Alessandro. Integrated immune gene expression signature and molecular classification in gastric cancer: New insights. Journal of Leukocyte Biology 2020; 108(2): 633 doi: 10.1002/JLB.4MR0120-221R
|
| 21 |
Bingjie Huo, Yanru Song, Bibo Tan, Jianbo Li, Jie Zhang, Fengbin Zhang, Liang Chang. Research on the mechanisms of taraxerol for the treatment of gastric cancer effect based on network pharmacology. International Journal of Immunopathology and Pharmacology 2022; 36 doi: 10.1177/20587384211063962
|
| 22 |
Xinyu Chong, Rui Peng, Yan Sun, Luyu Zhang, Zheng Zhang. Identification of Key Genes in Gastric Cancer by Bioinformatics Analysis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/7658230
|
| 23 |
Xinkui Liu, Jiarui Wu, Dan Zhang, Kaihuan Wang, Xiaojiao Duan, Ziqi Meng, Xiaomeng Zhang, Yoshiki Mukudai. Network Pharmacology‐Based Approach to Investigate the Mechanisms of Hedyotis diffusa Willd. in the Treatment of Gastric Cancer. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/7802639
|
| 24 |
Zhi Peng, Siyuan Cheng, Yan Kou, Ziqi Wang, Rong Jin, Han Hu, Xiaotian Zhang, Ji-fang Gong, Jian Li, Ming Lu, Xicheng Wang, Jun Zhou, ZhiHao Lu, Quan Zhang, David T.W. Tzeng, Dongtao Bi, Yan Tan, Lin Shen. The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer. Cancer Immunology Research 2020; 8(10): 1251 doi: 10.1158/2326-6066.CIR-19-1014
|
| 25 |
Rehan Ansari, Paolo Caimi, Ho Jun Lee, Zhengyi Chen, Arash Rashidi. Renal outcomes after chimeric antigen receptor T-cell therapy: a single-center perspective. Nephrology Dialysis Transplantation 2022; 37(9): 1777 doi: 10.1093/ndt/gfac048
|
| 26 |
Juanli Ji, Weiguo Zhen, Yuan Si, Wenjing Ma, Lanlan Zheng, Chen Li, Yonghong Zhang, Shanshan Qin, Te Zhang, Pengfei Liu, Xin Zheng, Ying Liu. Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer. Cancer Biomarkers 2018; 21(2): 307 doi: 10.3233/CBM-170416
|
| 27 |
Worawat Songjang, Chatchai Nensat, Sutatip Pongcharoen, Arunya Jiraviriyakul. The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review). Biomedical Reports 2021; 15(4) doi: 10.3892/br.2021.1462
|
| 28 |
Giuseppe Tirino, Luca Pompella, Angelica Petrillo, Maria Maddalena Laterza, Annalisa Pappalardo, Marianna Caterino, Michele Orditura, Fortunato Ciardiello, Gennaro Galizia, Ferdinando De Vita. What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives. International Journal of Molecular Sciences 2018; 19(9): 2659 doi: 10.3390/ijms19092659
|
| 29 |
Li-Bo Liang, Xin-Yan Huang, He He, Ji-Yan Liu. <p>Prognostic Values of Radiosensitivity Genes and CD19 Status in Gastric Cancer: A Retrospective Study Using TCGA Database</p>. Pharmacogenomics and Personalized Medicine 2020; : 365 doi: 10.2147/PGPM.S265121
|
| 30 |
Ji Xue, Ying Li, Jianfeng Yi, Hong Jiang. HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/6746970
|
| 31 |
Xu-Xu He, Bang Du, Tao Wu, Hao Shen. Prognostic analysis of related factors of adverse reactions to immunotherapy in advanced gastric cancer and establishment of a nomogram model. World Journal of Gastrointestinal Oncology 2024; 16(4): 1268-1280 doi: 10.4251/wjgo.v16.i4.1268
|
| 32 |
Qian Mao, Pin-Hu Zhang, Jie Yang, Jin-Di Xu, Ming Kong, Hong Shen, He Zhu, Min Bai, Li Zhou, Guang-Fu Li, Qiang Wang, Song-Lin Li, Isabel Andújar. iTRAQ‐Based Proteomic Analysis of Ginsenoside F2 on Human Gastric Carcinoma Cells SGC7901. Evidence-Based Complementary and Alternative Medicine 2016; 2016(1) doi: 10.1155/2016/2635483
|
| 33 |
Liang Han, Yanping Hao, Jianhua Wang, Zhengjiang Wang, Hongmei Yang, Xudong Wu. Knockdown of LINC02465 Suppresses Gastric Cancer Cell Growth and Metastasis Via PI3K/AKT Pathway. Human Gene Therapy Clinical Development 2019; 30(1): 19 doi: 10.1089/humc.2018.177
|
| 34 |
Fangxuan Li, Yao Sun, Jinchao Huang, Wengui Xu, Juntian Liu, Zhiyong Yuan. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis. Cancer Medicine 2019; 8(17): 7330 doi: 10.1002/cam4.2596
|
| 35 |
M. Gulubova, M. Hadzhi, M. Ignatova, D. Chonov, O. Balakan, M. Aydan, J. Ananiev. Novel Immunotherapeutic Approach in Gastric Cancer. Acta Medica Bulgarica 2020; 47(2): 47 doi: 10.2478/amb-2020-0024
|
| 36 |
Riccardo Dolcetti, Valli De Re. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; : 189 doi: 10.1007/978-3-030-04861-7_12
|
| 37 |
Jonadab E. Olguín, Itzel Medina-Andrade, Tonathiu Rodríguez, Miriam Rodríguez-Sosa, Luis I. Terrazas. Relevance of Regulatory T Cells during Colorectal Cancer Development. Cancers 2020; 12(7): 1888 doi: 10.3390/cancers12071888
|
| 38 |
Yongyuan Li, Hongjie Liu, Hekai Chen, Jianping Shao, Feng Su, Shupeng Zhang, Xuejun Cai, Xianghui He. DERL3 functions as a tumor suppressor in gastric cancer. Computational Biology and Chemistry 2020; 84: 107172 doi: 10.1016/j.compbiolchem.2019.107172
|
| 39 |
Weihuang Liu, Jie Zhao, Qiaoqi Li, Qiaona Wang, Ying Zhou, Zan Tong. Gastric cancer patients have elevated plasmacytoid and CD1c+ dendritic cells in the peripheral blood. Oncology Letters 2018; doi: 10.3892/ol.2018.7990
|
| 40 |
Yan Yang, Zong Xiu Yin, Zhao Yang Wang, Shu Bo Tian, Hong Chang Wang, Fang Xu Zhang, Le Ping Li, Chunning Zheng, Shuai Kong. miR-7641 depletion suppresses proliferation of gastric cancer cells by targeting ARID1A. Anti-Cancer Drugs 2020; 31(4): 368 doi: 10.1097/CAD.0000000000000881
|
| 41 |
Yiting Tian, Yang Xing, Zheng Zhang, Rui Peng, Luyu Zhang, Yan Sun. Bioinformatics Analysis of Key Genes and circRNA-miRNA-mRNA Regulatory Network in Gastric Cancer. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/2862701
|
| 42 |
Ming Zhang, Xiaoyu Wang, Zhenghua Wang. Early Study of Tumor Abnormal Protein in Gastric Adenocarcinoma. OncoTargets and Therapy 2021; : 1719 doi: 10.2147/OTT.S297413
|
| 43 |
Weizhi Chen, Zhongheng Yang, Chang Gu. Identification of Differentially Expressed Genes Reveals BGN Predicting Overall Survival and Tumor Immune Infiltration of Gastric Cancer. Computational and Mathematical Methods in Medicine 2021; 2021: 1 doi: 10.1155/2021/5494840
|
| 44 |
Juan Du, Baorui Liu. Personalized Management of Gastric Cancer. 2017; : 163 doi: 10.1007/978-981-10-3978-2_12
|
| 45 |
Li Feng, Jian Li, Fan Li, Huanqin Li, Songhua Bei, Xiaohong Zhang, Zhen Yang. Long noncoding RNA VCAN‐AS1 contributes to the progression of gastric cancer via regulating p53 expression. Journal of Cellular Physiology 2020; 235(5): 4388 doi: 10.1002/jcp.29315
|
| 46 |
Giandomenico Roviello, Alberto D’Angelo, Daniele Generali, Matteo Pittacolo, Monica Ganzinelli, Giandomenica Iezzi, Nicolò de Manzini, Navid Sobhani. Avelumab in Gastric Cancer. Immunotherapy 2019; 11(9): 759 doi: 10.2217/imt-2019-0011
|
| 47 |
Shiyu Zhang, Huiying Yang, Xuelian Xiang, Li Liu, Huali Huang, Guodu Tang. THBS2 is Closely Related to the Poor Prognosis and Immune Cell Infiltration of Gastric Cancer. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.803460
|
| 48 |
Zuwen Zhang, Jumei Zhao, Zhikuan Mi, Qiuxia Pang, Aihong Wang, Meini Chen, Xiaobin Liu, Xiaoli Wei, Tao Liu. Effects of salinomycin and 17-AAG on proliferation of human gastric cancer cells in vitro. Molecular Medicine Reports 2017; 16(2): 1063 doi: 10.3892/mmr.2017.6735
|
| 49 |
José Alexandre Ferreira, Ana Magalhães, Joana Gomes, Andreia Peixoto, Cristiana Gaiteiro, Elisabete Fernandes, Lúcio Lara Santos, Celso A. Reis. Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics. Cancer Letters 2017; 387: 32 doi: 10.1016/j.canlet.2016.01.044
|
| 50 |
Ting Wang, Hong-Jun Fei, Ye Yang, Xiao-Shu Jiang, Min Yan, Zhi Zeng, Jun Wu, Ling-Jun Song, Hua Tian, Guo-Hui Fu. Expression of AE1/p16 promoted degradation of AE2 in gastric cancer cells. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2751-x
|
| 51 |
Yajun Meng, Ze Jin, Mengmeng Wang, Di Chen, Mengpei Zhu, Yumei Huang, Shang Xia, Zhifang Xiong. Definition of a Novel Immunogenic Cell Death-Relevant Gene Signature Associated with Immune Landscape in Gastric Cancer. Biochemical Genetics 2023; 61(5): 2092 doi: 10.1007/s10528-023-10361-5
|
| 52 |
William H. Bisson, Amedeo Amedei, Lorenzo Memeo, Stefano Forte, Dean W. Felsher. Translational Toxicology and Therapeutics: Windows of Developmental Susceptibility in Reproduction and Cancer. 2017; : 473 doi: 10.1002/9781119023647.ch14
|
| 53 |
Qian Zhou, Xiaobin Wu, Chuangyu Wen, Huihui Wang, Huashe Wang, Huanliang Liu, Junsheng Peng. Toosendanin induces caspase-dependent apoptosis through the p38 MAPK pathway in human gastric cancer cells. Biochemical and Biophysical Research Communications 2018; 505(1): 261 doi: 10.1016/j.bbrc.2018.09.093
|
| 54 |
Xiaobo Guo, Ziguo Yang, Qiaoming Zhi, Dan Wang, Lei Guo, Guimei Li, Ruizhen Miao, Yulong Shi, Yuting Kuang. Long noncoding RNA OR3A4 promotes metastasis and tumorigenicity in gastric cancer. Oncotarget 2016; 7(21): 30276 doi: 10.18632/oncotarget.7217
|
| 55 |
Noriyuki Hirahara, Yoshitsugu Tajima, Yusuke Fujii, Shunsuke Kaji, Yasunari Kawabata, Ryoji Hyakudomi, Tetsu Yamamoto, Takahito Taniura. Controlling Nutritional Status (CONUT) as a prognostic immunonutritional biomarker for gastric cancer after curative gastrectomy: a propensity score-matched analysis. Surgical Endoscopy 2019; 33(12): 4143 doi: 10.1007/s00464-019-06723-z
|
| 56 |
Marta Jessica Llorca-Cardeñosa, Tania Fleitas, Maider Ibarrola-Villava, María Peña-Chilet, Cristina Mongort, Carolina Martinez-Ciarpaglini, Lara Navarro, Valentina Gambardella, Josefa Castillo, Susana Roselló, Samuel Navarro, Gloria Ribas, Andrés Cervantes. Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment. Oncotarget 2016; 7(39): 63424 doi: 10.18632/oncotarget.11520
|
| 57 |
Jianjun Peng. si‑TP73‑AS1 suppressed proliferation and increased the chemotherapeutic response of GC cells to cisplatin. Oncology Letters 2018; doi: 10.3892/ol.2018.9107
|
| 58 |
Jian Shao, Wenjia Zhang, Yiguang Li, Yi Tang, Lihong Fan. Metabolic and immune‐related gene signatures: Predictive stratification and prognostic implications in gastric cancer. The Journal of Gene Medicine 2024; 26(1) doi: 10.1002/jgm.3635
|
| 59 |
Min Mao, Qingliang Yu, Rongzhi Huang, Yunxin Lu, Zhen Wang, Liang Liao. Stromal score as a prognostic factor in primary gastric cancer and close association with tumor immune microenvironment. Cancer Medicine 2020; 9(14): 4980 doi: 10.1002/cam4.2801
|
| 60 |
Biao Yang, Yingnan Wang, Tao Liu, Meijing Zhang, Tianhang Luo. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma. Aging 2024; doi: 10.18632/aging.205690
|
| 61 |
Yan Zhao, Yuansong Bai, Meili Shen, Yapeng Li. Therapeutic strategies for gastric cancer targeting immune cells: Future directions. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.992762
|
| 62 |
Yasuhiko Mohri, Yuji Toiyama, Masato Kusunoki. Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics. Expert Review of Proteomics 2016; 13(12): 1131 doi: 10.1080/14789450.2016.1249469
|
| 63 |
Yi Li, Qin Pan, Mingxia Cheng, Zhengyuan Wu. Identification and validation of anoikis-associated gene SNCG as a prognostic biomarker in gastric cancer. Aging 2023; 15(7): 2541 doi: 10.18632/aging.204626
|
| 64 |
Elnaz Faghfuri, Mahdi Abdoli Shadbad, Amir Hossein Faghfouri, Narges Soozangar. Cellular Immunotherapy in Gastric Cancer: Adoptive Cell Therapy and Dendritic Cell-Based Vaccination. Immunotherapy 2022; 14(6): 475 doi: 10.2217/imt-2021-0285
|
| 65 |
Xiaodong Huang, Jie Zhang, Yongbin Zheng. ANTXR1 Is a Prognostic Biomarker and Correlates With Stromal and Immune Cell Infiltration in Gastric Cancer. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.598221
|
| 66 |
Feng Wang, Cheng Chen, Wei-Peng Chen, Zu-Ling Li, Hui Cheng, Syed Sameer Aga. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6014202
|
| 67 |
George Alzeeb, Danielle Arzur, Valérie Trichet, Matthieu Talagas, Laurent Corcos, Catherine Le Jossic-Corcos. Gastric cancer cell death analyzed by live cell imaging of spheroids. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-05426-1
|
| 68 |
Alessandro Cavaliere, Valeria Merz, Simona Casalino, Camilla Zecchetto, Francesca Simionato, Hayley Louise Salt, Serena Contarelli, Raffaela Santoro, Davide Melisi. Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer. Journal of Gastric Cancer 2019; 19(4): 375 doi: 10.5230/jgc.2019.19.e39
|